Inserm

News Inserm

• Clarifying the effect of stem cell therapy on cancer

  Injection of human stem cells into mice with tumors slowed down tumor growth, finds research published in BioMed Central's open access journal Stem Cell Research & Therapy. Human mesenchymal stem cells (MSC), isolated from bone marrow, caused changes in blood vessels supplying the tumor, and it is t more

• NEUROKIN receives support from ANR on its STROKININ project

  NEUROKIN announced that it has received the support from the Agence Nationale de la Recherche (ANR) on its STROKININ project aiming at improving the development of NK-102, its most advanced neuroprotective drug for the treatment of stroke. This 36 months duration project with a global budget of € 1. more

• Mount Sinai researchers find potential therapeutic target across a range of cancer types

  Researchers from Mount Sinai School of Medicine, in collaboration with investigators of the National Institute of Health and Medical Research (INSERM) of France led by Nicolae Ghinea, PhD, have found a common link among several malignant tumor types in all grades of cancer. This breakthrough may ult more

Publications Inserm

• Modeling risk stratification in human cancer

  Motivation: Despite huge prognostic promises, gene expression-based survival assessment is rarely used in clinical routine. Main reasons include difficulties in performing and reporting analyses and restriction in most methods to one high-risk group with the vast majority of patients being unassess more

• Commentary: Ion Channels, Fusion Pores and Exocytosis

  Commentary: Ion Channels, Fusion Pores and Exocytosis Content Type Journal Article Pages 1-3 DOI 10.1007/s12031-012-9794-5 Authors Emilio Carbone, Department of Neuroscience, NIS Center, National Institute of Neuroscience, University of Torino, 10125 Torino, Italy Nathalie C. Guérineau, more

• Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!

  Stay vigilant: a glitazone (pioglitazone) can hide a glitazar! Content Type Journal Article Category Letter to the Editors Pages 1-3 DOI 10.1007/s00228-012-1299-1 Authors Dominique Hillaire-Buys, Department of Medical Pharmacology and Toxicology, CHRU Montpellier and INSERM U1058, Montp more

Websites Inserm